4-methylcyclohex-3-en-1-ol | 93915-81-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-methylcyclohex-3-en-1-ol
• 英文别名: (1S)-4-methylcyclohex-3-en-1-ol
• CAS: 93915-81-2
• 化学式: C₇H₁₂O
• 分子量: 112.172
• InChiKey: SHRVHWWZRZPZFL-SSDOTTSWSA-N

物化性质

• 沸点：
  174.1±19.0 °C(Predicted)
• 密度：
  0.977±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-methylcyclohex-3-en-1-ol 在 吡啶 、 sodium azide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 7.5h， 生成 (1R)-1-叠氮基-4-甲基-3-环己烯
  参考文献：
  名称：

  Trichodiene synthase. Synergistic inhibition by inorganic pyrophosphate and aza analogs of the bisabolyl cation.

  摘要：

  A series of aza analogs of the bisabolyl and alpha-terpinyl cations were tested as inhibitors of the sesquiterpene cyclase, trichodiene synthase. Both (R)- and (S)-16 and (R)- and (S)-13 as well as trimethylamine were only weak inhibitors when incubated alone. In the presence of inorganic pyrophosphate, itself a known competitive inhibitor of trichodiene synthase, all five amines showed strong cooperative competitive inhibition with an enhancement factor estimated to be 10-40. The apparent induced inhibition constant alpha-K(j) decreased in going from trimethylamine to the monoterpene analogs 13 and was strongest for the sesquiterpene analogs 16, indicating that both electrostatic and hydrophobic interactions are important in the binding of each intermediate analog. The cyclase showed little discrimination, however, between the individual enantiomers of each inhibitor.

  DOI：

  10.1021/jo00038a040
• 作为产物：
  描述：

  (+)-(1R)-4-methyl-3-cyclohexen-1-ol 在 吡啶 、 lithium aluminium tetrahydride 作用下， 以 乙醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 16.5h， 生成 4-methylcyclohex-3-en-1-ol
  参考文献：
  名称：

  Trichodiene synthase. Synergistic inhibition by inorganic pyrophosphate and aza analogs of the bisabolyl cation.

  摘要：

  A series of aza analogs of the bisabolyl and alpha-terpinyl cations were tested as inhibitors of the sesquiterpene cyclase, trichodiene synthase. Both (R)- and (S)-16 and (R)- and (S)-13 as well as trimethylamine were only weak inhibitors when incubated alone. In the presence of inorganic pyrophosphate, itself a known competitive inhibitor of trichodiene synthase, all five amines showed strong cooperative competitive inhibition with an enhancement factor estimated to be 10-40. The apparent induced inhibition constant alpha-K(j) decreased in going from trimethylamine to the monoterpene analogs 13 and was strongest for the sesquiterpene analogs 16, indicating that both electrostatic and hydrophobic interactions are important in the binding of each intermediate analog. The cyclase showed little discrimination, however, between the individual enantiomers of each inhibitor.

  DOI：

  10.1021/jo00038a040

文献信息

• Stereoselective [4+2]‐Cycloaddition with Chiral Alkenylboranes
  作者：Dongshun Ni、Brittany P. Witherspoon、Hong Zhang、Chen Zhou、K. N. Houk、M. Kevin Brown

  DOI：10.1002/anie.202000652

  日期：2020.7.6

  A method for the stereoselective [4+2]‐cycloaddition of alkenylboranes and dienes is presented. This transformation was accomplished through the introduction of a new strategy that involves the use of chiral N‐protonated alkenyl oxazaborolidines as dieneophiles. The reaction leads to the formation of products that can be readily derivatized to more complex structural motifs through stereospecific transformations

  提出了一种方法用于烯基硼烷和二烯的立体选择[4 + 2]-环加成反应。这种转化是通过引入一种新策略完成的，该策略涉及使用手性N质子化的烯基恶唑硼烷作为二烯亲和体。该反应导致形成产物，该产物可以通过C-B键的立体定向转化（例如氧化和同源化）而容易地衍生为更复杂的结构图案。反应的详细计算评估发现反离子对立体选择性的惊人作用。
• Alkylhalovinylboranes: a new class of Diels–Alder dienophiles
  作者：Pablo L. Pisano、Silvina C. Pellegrinet

  DOI：10.1039/c8ra07089j

  日期：——

  The Diels–Alder reactions of alkylhalovinylboranes have been investigated theoretically and experimentally. Alkylhalovinylboranes presented higher reactivity than the corresponding dialkylvinylboranes. Although endo/exo selectivities were high for the reactions with cyclopentadiene, facial selectivities for the chiral analogues were low. Our results demonstrate that the replacement of an alkyl group

  烷基卤乙烯基硼烷的 Diels-Alder 反应已在理论上和实验上进行了研究。烷基卤代乙烯基硼烷比相应的二烷基乙烯基硼烷具有更高的反应性。尽管与环戊二烯反应的内/外选择性很高，但手性类似物的面部选择性却很低。我们的结果表明，硼原子上的烷基被卤素取代会显着增加亲二烯性。
• SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE
  申请人：Signal Pharmaceuticals, LLC

  公开号：US20150210650A1

  公开（公告）日：2015-07-30

  Provided herein are formulations, processes, solid forms and methods of use relating to 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide.

  本文提供了与2-(叔丁基氨基)-4-((1R,3R,4R)-3-羟基-4-甲基环己基氨基)-嘧啶-5-羧酰胺相关的配方、工艺、固体形式和使用方法。
• 2-Amino Quinazoline Derivative
  申请人：Nakasato Yoshisuke

  公开号：US20070225308A1

  公开（公告）日：2007-09-27

  The present invention provides a compound represented by Formula (I) (wherein R 1 and R 2 are the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like, R 3 represents substituted or unsubstituted aryl, a substituted or unsubstituted aromatic heterocyclic group and the like, R 4 and R 5 are the same or different, and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl and the like, proviso that they are not simultaneously hydrogen atoms, and R 6 represents hydroxy or substituted or unsubstituted lower alkoxy), or a pharmaceutically acceptable salt thereof and the like.

  本发明提供了一种由式（I）表示的化合物（其中R1和R2相同或不同，分别表示氢原子，取代或未取代的低级烷基等，R3表示取代或未取代的芳基，取代或未取代的芳香族杂环基等，R4和R5相同或不同，分别表示氢原子，卤素，取代或未取代的低级烷基，取代或未取代的芳基等，但它们不能同时是氢原子，R6表示羟基或取代或未取代的低级烷氧基），或其药学上可接受的盐等。
• Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
  申请人：Signal Pharmaceuticals, LLC

  公开号：US10226461B2

  公开（公告）日：2019-03-12

  Provided herein are formulations, processes, solid forms and methods of use relating to 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide.

  本文提供了与 2-(叔丁基氨基)-4-((1R,3R,4R)-3-羟基-4-甲基环己基氨基)-嘧啶-5-甲酰胺有关的制剂、工艺、固体形式和使用方法。